Compound 1155
Identifiers
- Canonical SMILES:
CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(cc1S(=O)(=O)C(C)(C)C)S(=O)(=O)Nc1ncnc2CN(CCc12)C1CCN(Cc2c(F)cccc2-c2ccc(Cl)cc2)CC1
- InChi:
InChI=1S/C47H57ClFN7O4S3/c1-47(2,3)62(57,58)45-28-38(18-19-43(45)52-35(20-24-54(4)5)31-61-37-10-7-6-8-11-37)63(59,60)53-46-40-23-27-56(30-44(40)50-32-51-46)36-21-25-55(26-22-36)29-41-39(12-9-13-42(41)49)33-14-16-34(48)17-15-33/h6-19,28,32,35-36,52H,20-27,29-31H2,1-5H3,(H,50,51,53)/t35-/m1/s1
- InChiKey:
GWIBQGRPRSORRM-PGUFJCEWSA-N
External links
![]() 168317810 |
External search
![]() |
![]() |
![]() |
![]() |
![]() |
Bibliography (1)
Publication | Name |
---|---|
Karen Miller-Moslin, Bakary-Barry Toure, Michael Scott Visser, Naeem Yusuff, Novartis Ag. . Sulfonamides as inhibitors of bcl-2 family proteins for the treatment of cancer None. | 21 |
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
BCL2-Like / BAX | 7.52 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 933.33 g/mol | |||
HBA | 11 | |||
HBD | 2 | |||
HBA + HBD | 13 | |||
AlogP | 6.05 | |||
TPSA | 127.84 | |||
RB | 16 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
WO2011029842 | 21 | BCL2 P10415 |
|
Biochemical assay | Surface Plasmon Resonance | pIC50 (half maximal inhibitory concentration, -log10) | 7.52 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.4675 | Navitoclax | DB12340 | |
0.3920 | GDC-0349 | DB13072 | |
0.3878 | N-{2-[6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2,2-DIMETHYL-3-OXO-2,3-DIHYDRO-4H-1,4-BENZOTHIAZIN-4-YL]ETHYL}ACETAMIDE | DB06899 | |
0.3815 | Sulfaisodimidine | DB13283 | |
0.3775 | Sparsentan | DB12548 | |
0.3677 | N-(2-(((5-CHLORO-2-PYRIDINYL)AMINO)SULFONYL)PHENYL)-4-(2-OXO-1(2H)-PYRIDINYL)BENZAMIDE | DB07800 | |
0.3676 | Presatovir | DB12165 | |
0.3639 | PF-232798 | DB14813 | |
0.3612 | 4-[(5-CHLOROINDOL-2-YL)SULFONYL]-2-(2-METHYLPROPYL)-1-[[5-(PYRIDIN-4-YL)PYRIMIDIN-2-YL]CARBONYL]PIPERAZINE | DB04673 | |
0.3600 | Lenacapavir | DB15673 | |
0.3555 | Quinupristin | DB01369 | |
0.3532 | TAK-901 | DB12756 | |
0.3492 | Nelivaptan | DB12643 | |
0.3492 | Tianeptine | DB09289 | |
0.3490 | (3R,4S)-1-{6-[3-(METHYLSULFONYL)PHENYL]PYRIMIDIN-4-YL}-4-(2,4,5-TRIFLUOROPHENYL)PYRROLIDIN-3-AMINE | DB07666 |